---
title: Targeting the receptor tyrosine kinase MerTK shows therapeutic value in gastric
  adenocarcinoma
date: '2024-03-28'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38545840/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240328180704&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Our findings demonstrate the potential value of MerTK as
  a prognostic biomarker for gastric adenocarcinoma. Targeting MerTK may become a
  new treatment option, especially for patients with advanced tumors, and may overcome
  resistance to established ...'
disable_comments: true
---
CONCLUSIONS: Our findings demonstrate the potential value of MerTK as a prognostic biomarker for gastric adenocarcinoma. Targeting MerTK may become a new treatment option, especially for patients with advanced tumors, and may overcome resistance to established ...